Pro Dex (PDEX) Cash from Investing Activities (2010 - 2026)
Pro Dex (PDEX) reported Cash from Investing Activities of -$5.1 million for Q1 2026, down 392.7% on a YoY basis from $1.7 million in Q1 2025, and down 157.0% sequentially from $8.9 million in Q4 2025.
Pro Dex (PDEX) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Pro Dex (PDEX) has 15 years of Cash from Investing Activities data on file, last reported at -$5.1 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities fell 392.7% year-over-year to -$5.1 million; the trailing twelve-month figure through Mar 2026 stood at $2.7 million (up 320.87% YoY), and the FY2025 full-year result was -$238000.0, up 89.34% from the prior year.
- Cash from Investing Activities slipped to -$5.1 million in Q1 2026, from $8.9 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $8.9 million in Q4 2025 to a low of -$5.1 million in Q1 2026.
- A 5-year average of $32588.2 and a median of -$135000.0 in 2023 frame the typical range for Cash from Investing Activities.
- Peak annual rise in Cash from Investing Activities reached 1736.16% in 2025, while the deepest fall reached 827.1% in 2025.
- Tracing PDEX's Cash from Investing Activities over 5 years: stood at -$508000.0 in 2022, then plunged by 270.67% to -$1.9 million in 2023, then surged by 71.22% to -$542000.0 in 2024, then jumped by 1736.16% to $8.9 million in 2025, then plunged by 157.0% to -$5.1 million in 2026.
- Business Quant data shows PDEX's Cash from Investing Activities at -$5.1 million in Q1 2026, $8.9 million in Q4 2025, and -$98000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.25 Bn | 121.03 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 44.77 Bn | 43.96 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Alcon | 32.95 Bn | 31.29 Bn | 1.53 Bn | -218.00 Mn |
| 4 | Medline | 32.87 Bn | 30.63 Bn | 1.84 Bn | -96.00 Mn |
| 5 | Resmed | 29.48 Bn | 27.82 Bn | 890.98 Mn | -58.03 Mn |
| 6 | West Pharmaceutical Services | 23.51 Bn | 23.07 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 14.01 Bn | 13.45 Bn | 1.10 Bn | -77.00 Mn |
| 8 | Cooper Companies | 13.77 Bn | 13.63 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Align Technology | 12.05 Bn | 10.99 Bn | 736.59 Mn | -131.58 Mn |
| 10 | Pro Dex | 182.13 Mn | 173.08 Mn | 6.13 Mn | -5.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.06 Mn |
| Mar 31, 2026 | -5.06 Mn |
| Dec 31, 2025 | 8.87 Mn |
| Dec 31, 2025 | 8.87 Mn |
| Sep 30, 2025 | -98,000.00 |
| Sep 30, 2025 | -98,000.00 |
| Jun 30, 2025 | -992,000.00 |
| Jun 30, 2025 | -992,000.00 |
| Mar 31, 2025 | 1.73 Mn |
| Mar 31, 2025 | 1.73 Mn |
| Dec 31, 2024 | -542,000.00 |
| Dec 31, 2024 | -542,000.00 |
| Sep 30, 2024 | -431,000.00 |
| Sep 30, 2024 | -431,000.00 |
| Jun 30, 2024 | -107,000.00 |
| Jun 30, 2024 | -107,000.00 |
| Mar 31, 2024 | -117,000.00 |
| Mar 31, 2024 | -117,000.00 |
| Dec 31, 2023 | -1.88 Mn |
| Dec 31, 2023 | -1.88 Mn |